“…Among different surgical approaches, Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) has been considered a valid surgical treatment option for PCa patients [1] , [3] , [4] , [5] , [6] , [7] . However, differently from the anterior robot-assisted radical prostatectomy (RARP) and retropubic open prostatectomy, clinicians are sceptic regarding a possible role of the posterior approach (ie, RS-RARP) in the high-risk PCa setting, given the lack of high-level evidence on this subset of patients and a concern that RS-RARP may confer an increased positive surgical margin (PSM) rate [1] , [6] . The majority of the available studies on RS-RARP focused exclusively on low- and intermediate-risk PCa [1] , [3] , [4] , [6] , [8] , [9] , [10] .…”